4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-26-022980
Chief Operating Officer sold 7,500 shares at an average $6.09 ($45,680)
- Chief Operating Officer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ye Weiguo · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-22 | Exercise or conversion : show line 1 in the form | +3,500 | $0.75 | $2,625 | 703,500 | D |
| 2026-05-22 | Sale : show line 2 in the form | −3,500 | $6.08 | $21,280 | 700,000 | D |
| 2026-05-26 | Exercise or conversion : show line 3 in the form | +4,000 | $0.75 | $3,000 | 704,000 | D |
| 2026-05-26 | Sale : show line 4 in the form | −4,000 | $6.10 | $24,400 | 700,000 | D |
| Open-market sales · 7,500 sh · avg $6.09 · $45,680 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-22 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −3,500 | 901,395 | D |
| 2026-05-26 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −4,000 | 897,395 | D |
Loading xslF345X06/form4.xml…